Morgan Stanley
-
-
-
-
-
-
-
Rhythm Pharmaceuticals announces $150 million stock offering
-
-
-
-
-
-
-
Rhythm Pharmaceuticals Enters into a Non-dilutive Revenue Interest Financing Agreement with HealthCare Royalty for up to $100 Million
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) Prices 5M Share Common Offering at $30/Sh
-
-
-
-
-
-
-
Rhythm Pharmaceuticals to Present at Investor Conferences in September
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) Announces Proposed $150M Share Offering
-
-
-
-
-
-
-
Rhythm Pharmaceuticals to Present at Morgan Stanley 16th Annual Global Healthcare Conference
-
-
-
-
-
-
-
Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
-
226,219 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

